Crossref
Localized amyloidosis following COVID-19 vaccination with possible immune-mediated pathogenesis
European Journal of Dermatology · 2026-02 · 36 (1) · 57-58
DOI: 10.1684/ejd.2026.5017 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2026-02. Verfasst von Minami Aizawa und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Aizawa, M., & Sugita, K. (2026). Localized amyloidosis following COVID-19 vaccination with possible immune-mediated pathogenesis. European Journal of Dermatology, 36(1), 57-58. https://doi.org/10.1684/ejd.2026.5017
Vancouver
Aizawa M, Sugita K. Localized amyloidosis following COVID-19 vaccination with possible immune-mediated pathogenesis. European Journal of Dermatology. 2026;36(1):57-58. doi:10.1684/ejd.2026.5017
BibTeX
@article{Aizawa2026,
author = {Aizawa, Minami and Sugita, Kazunari},
title = {Localized amyloidosis following COVID-19 vaccination with possible immune-mediated pathogenesis},
journal = {European Journal of Dermatology},
year = {2026},
volume = {36},
number = {1},
pages = {57--58},
doi = {10.1684/ejd.2026.5017}
}
EUVIMED